Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;44(1):70-74.
doi: 10.5152/tud.2017.81592. Epub 2017 Dec 19.

The role of the neurometer CPT/C in sacral neuromodulation

Abdullah Ahmed Ghazi  1 , Malak Abuzgaya  1 , Mai Banakhar  2 , Magdy Hassouna  1
Affiliations

The role of the neurometer CPT/C in sacral neuromodulation

Abdullah Ahmed Ghazi et al. Turk J Urol. 2018 Jan.

Abstract

Objective: The aim of the current research project was to study the role of the Neurometer® as a tool to predict responders to sacral neuromodulation therapy (SNM).

Material and methods: This was a prospective, open study in male and female patients, aged 18 and over with voiding dysfunction [non-obstructive retention and/or frequency/ urgency syndrome]. The first group underwent a screening test to evaluate percutaneous nerve functions (PNE) and to determine whether they are candidates for SNM with the InterStim®. Prior to PNE testing, all patients were evaluated with the pain tolerance test (PTT) using the electro-diagnostic Neurometer® CPT/C device. An InterStim® implant was placed in patients who were responders to PNE testing underwent. On the other hand, non-responders underwent a staged implant placement. The second group consisted of patients who already had InterStim® implanted for voiding dysfunction. During the routine office follow-up, the patients implanted with Interstim® underwent a PTT using the Neurometer® CPT/C device. All the testing using the Neurometer CPT/C was performed on the day of the PNE for the first group, and the day of the routine follow-up visit for the second group. All of the results for the Neurometer® testing were kept blinded from the PNE results, and those of the outcome of the follow-up visit. The study received approval by the Research Ethics Board of the University Health Network (No. 14-8196).

Results: We recruited a total of 123 patients. The results presented here include 110 patients who completed the study, 48 of whom were in the first group, and 62 in the second group. The statistical analysis used was as follows: Group 1: Simple linear regression analysis and the linear discriminate analysis were preformed. It was found that for patients without the InterStim® implant with a combined CPT/CPD of 800 and above, the Neurometer® could predict the test screening results with an accuracy of 71%. Group 2: Same analysis and tests were conducted for patients with the InterStim® implant, and the results showed that if the patient had a combined CPT/CPD of 600 and above, the Neurometer® could predict the patients satisfaction or dissatisfaction with an accuracy of 72%.

Conclusion: Neurometer® may play a role in predicting test trial positive responders and patient satisfaction after the placement of InterStim® implant.

Keywords: Electrical nerve stimulation; Percutaneous Nerve Evaluation (PNE); electrodiagnosis; frequency-urgency syndrome; response to sacral nerve stimulation test trial; sacral neuromodulation; sensory nerve pain threshold; urinary urge incontinence.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No conflict of interest was declared by the authors.

Figures

Figure 1
Figure 1
Dermatome map
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Janknegt RA, Weil EH, Eerdmans PH. Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology. 1997;49:358–62. https://doi.org/10.1016/S0090-4295(96)00506-7. - DOI - PubMed
    1. Peters KM, Carey JM, Konstandt DB. Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:223–8. https://doi.org/10.1007/s00192-003-1070-3. - DOI - PubMed
    1. Al-zahrani AA, Elzayat EA, Gajewski JB. Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center. J Urol. 2011;185:981–6. https://doi.org/10.1016/j.juro.2010.10.054. - DOI - PubMed
    1. McLennan M. The Role of electrodiagnostic technidues in the reprogramming of patients with delayed suboptimal response to sacral nerve stimulation. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:98–103. https://doi.org/10.1007/s00192-002-1029-9. - DOI - PubMed
    1. Staskin DR, Wein AJ, Andersson KE, Bauer SB, Blaivas JG, Burgio KL, et al. Overview consensus statement. Urology. 2002;60(5 Suppl 1):1–6. - PubMed

LinkOut - more resources